301580.SZ
爱迪特
SZSE · Healthcare · C 制造业 · CN
CNY 48.96
−4.64%Year over year
Reported trailing growth
- Revenue
- +18.2%
- EBITDA
- —
- EBIT
- +23.4%
- EPS
- +6.2%
- Free cash flow
- +23.8%
- Operating cash flow
- +39.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +19.7%
- EBITDA
- +20.9%
- EBIT
- +17.4%
- Net income
- +19.2%
- EPS
- -3.2%
- Free cash flow
- +6.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026